Article

Prevalence of depression among US adults with diabetes - Findings from the 2006 behavioral risk factor surveillance system

Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control, Atlanta, Georgia 30341, USA.
Diabetes care (Impact Factor: 8.57). 01/2008; 31(1):105-7. DOI: 10.2337/dc07-1154
Source: PubMed

ABSTRACT To estimate the prevalence rate of depression among adults with diabetes using a large population-based sample in the U.S.
Data from the 2006 Behavioral Risk Factor Surveillance System, a standardized telephone survey among U.S. adults aged >or=18 years, were analyzed (n = 18,814). The Patient Health Questionnaire diagnostic algorithm was used to identify major depression.
The age-adjusted prevalence rate of major depression was 8.3% (95% CI 7.3-9.3), ranging from a low of 2.0% in Connecticut to a high of 28.8% in Alaska. There were 25-fold differences in the rate among racial/ethnic subgroups (lowest, 1.1% among Asians; highest, 27.8% among American Indians/Alaska Natives). People with type 2 diabetes who were currently using insulin had a higher rate than people with type 1 diabetes (P = 0.0009) and those with type 2 diabetes who were currently not using insulin (P = 0.01).
Major depression was highly prevalent among people with diabetes; the prevalence rate varied greatly by demographic characteristics and diabetes types.

Full-text

Available from: Tara Strine, Feb 04, 2014
0 Followers
 · 
82 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patiënten en methoden In een mixed methods-onderzoek werd onder volwassen diabetespatiënten (type 1 en type 2) met een of meer complicaties in een online survey het psychologisch welzijn in kaart gebracht (HADS-angst, HADS-depressie, PAID-diabetesdistress, EQ-5D kwaliteit van leven, functionele en emotionele beperkingen). Tevens werd met focusgroepen verdieping gezocht naar de (psychosociale) zorgbehoefte van diabetespatiënten. Patiënten konden zichzelf aanmelden en alle gegevens zijn zelf-gerapporteerd om het patiëntperspectief in kaart te kunnen brengen. Resultaten Bij 36,2% van de 273 deelnemende patiënten is sprake van een of meerdere psychologische problemen. Patiënten met twee of meer complicaties rapporteren meer psychologische klachten dan mensen met één complicatie. Mensen rapporteren weinig fysieke en emotionele beperkingen voor iedere complicatie afzonderlijk. Van de deelnemende patiënten heeft 13,6% psychologische hulp (gehad) voor het omgaan met complicaties en 23,7% had dat wel graag gewild. Uit de focusgroepen blijkt dat beleving van de ziekte diabetes en de complicaties ervan voor de patiënten onlosmakelijk met elkaar verbonden zijn. Patiënten geven aan dat hun angsten niet goed begrepen worden en dat er te weinig aandacht is voor de psychische kant. Bij de diagnose diabetes zou direct een gesprek met de psycholoog moeten plaatsvinden, maar ook wanneer men complicaties krijgt. Psychologen en psychiaters zijn echter vaak onvoldoende bekend met diabetes. Ook kan de communicatie tussen de zorgprofessionals (artsen, verpleegkundigen en psychologen/psychiaters) beter. Conclusie De meeste patiënten adapteren aan hun functionele beperkingen en ervaren complicaties als integraal onderdeel van het leven met diabetes. Ruim een derde ervaart klinisch relevante psychische klachten. De psychologische zorg kan worden verbeterd in termen van screening, communicatie tussen zorgverleners en kennis over diabetes bij psychologen.
    02/2015; 13(1):4-9. DOI:10.1007/s12467-015-0002-4
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Summary Despite research efforts in the past 20 years, scientific evidence about screening and treatment for depression in diabetes remains incomplete and is mostly focused on North American and European health-care systems. Validated instruments to detect depression in diabetes, although widely available, only become effective and thus recommended if subsequent treatment pathways are accessible, which is often not the case. Because of the well known adverse effects of the interaction between depression and diabetes, treatment goals should focus on the remission or improvement of depression as well as improvement in glycaemic control as a marker for subsequent diabetes outcome. Scientific evidence evaluating treatment for depression in type 1 and type 2 diabetes shows that depression can be treated with moderate success by various psychological and pharmacological interventions, which are often implemented through collaborative care and stepped-care approaches. The evidence for improved glycaemic control in the treatment of depression by use of selective serotonin reuptake inhibitors or psychological approaches is conflicting; only some analyses show small to moderate improvements in glycaemic control. More research is needed to evaluate treatment of different depression subtypes in people with diabetes, the cost-effectiveness of treatments, the use of health-care resources, the need to account for cultural differences and different health-care systems, and new treatment and prevention approaches.
    05/2015; DOI:10.1016/S2213-8587(15)00045-5
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. The emotional consequences of diabetes have been scrutinized by a number of investigative teams and there are varying reports about the association of depression with type 2 diabetes mellitus. However, there is limited data about this in Ethiopia. Therefore, the purpose of this study was to assess the prevalence of comorbid depression among type 2 diabetic outpatients. Methods and Materials. Institution based cross-sectional study design was conducted on a random sample of 276 type 2 diabetic outpatients from Black Lion General Specialized Hospital. Systematic random sampling technique was used to get these individual patients from 920 type 2 diabetic outpatients who have an appointment during the data collection period. Patients’ depression status was measured using Patient Health Questionnaire 9 (PHQ 9). Result. Totally 264 type 2 diabetic outpatients were interviewed with a response rate of 95.6%. The prevalence of depression among type 2 diabetic outpatients was 13%. Based on PHQ 9 score, 28.4% (75) fulfilled the criteria for mild depression, 12.1% (32) for moderate depression, 2.7% (7) for moderately severe depression, and 1.5% (4) for severe depression. But 45.8% (121) of patients had no clinically significant depression. Conclusion. This study demonstrated that depression is a common comorbid health problem in type 2 diabetic outpatients with a prevalence rate of 13%.
    Depression research and treatment 02/2015; 2015:1-8. DOI:10.1155/2015/184902